Sublingual
tablets; Alpha-Chymotrypsin 2.5 mg; Escharase 40
mg; Activity 1000 GDU activity/tablet
>anti-inflammatory<
Kymozym™ formula combines the
anti-inflammatory action of escharase--a non-proteolytic
principle of the Bromelain group--and Alpha-Chymotrypsin
of beef pancrease. The Kymozym™ tablets are
designed for buccal use which facilitates
instantaneous cross-membrane activation of
Plasminogen and the absorption of substantial
amounts of intact enzyme factors.
Main
uses of Kymozym™ tablets include:
 |
Post
operative administration for use in
cosmetic, dental or general surgery
|
 |
Pain
relief in spasmodic dysmenorrhea and/or
shortening of labor
|
|
Minor
aches and pains including back strain and/or
persistent muscle soreness
|
Dosage
and administration of Kymozym differs depending on
its intended use.
Nutritional
note...In
a 1961 study, 80% of patients using an escharase
and/or alpha-chymotrypsin formula after surgery
exhibited a marked reduction in pain, fever,
swelling and inflammation. In other studies
scientists also found acceleration of wound
healing and remarkable reduction in scar tissue
formation (this action is probably due to the
systemic action of escharase, a prostaglandin-e
activator of the Bromelain enzyme group).
